NLS Pharmaceutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2024 | 5.75 M | $1.25 M | 0.00% | 15.05% |
| ARMISTICE CAPITAL, LLC | 08/14/2024 | 2.31 M | $501,256 | 6.40% | 6.05% |
| UBS GROUP AG | 08/14/2024 | 235,723 | $51,152 | 100.00% | 0.62% |
| CITADEL ADVISORS LLC | 08/14/2024 | 136,270 | $29,557 | 610.37% | 0.36% |
| JANE STREET GROUP, LLC | 08/15/2024 | 43,672 | $9,473 | 100.00% | 0.11% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 21,777 | $4,723 | -87.87% | 0.06% |
| HRT FINANCIAL LP | 08/12/2024 | 16,832 | $3,000 | 100.00% | 0.04% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 14,362 | $3,115 | 0.00% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 90 | $19 | 0.00% | 0.00% |
| XTX TOPCO LTD | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
NLS Pharmaceutics AGinstitutional Ownership - FAQ's
During the previous two years, 9 institutional investors and hedge funds held shares of NLS Pharmaceutics AG. The most heavily invested institutionals were:
BANK OF AMERICA CORP /DE/: 0
BVF INC/IL: 0
RENAISSANCE TECHNOLOGIES LLC: 0
GEODE CAPITAL MANAGEMENT, LLC: 0
CITADEL ADVISORS LLC: 0
JANE STREET GROUP, LLC: 0
22.34% of NLS Pharmaceutics AG stock is owned by institutional investors.